LIMNW
Liminatus Pharma, Inc.
$0.05
today
Price History
Not enough data
Key Stats
Market Cap
—
Avg Volume
88
52W High
$0.05
52W Low
$0.05
Div. Yield
0.0%
Valuation
P/B Ratio
0.18
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Assets
(95.7%)
Liquidity & Leverage
Current Ratio
1.12
Quick Ratio
0.99
Debt / Equity
4.80
Total Cash
3.02M
Total Debt
1.44M
About
Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
liminatuspharma.com